2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Cancer Drugs Market
The sales of cancer drugs and related services by entities (organizations, sole traders, and partnerships) that create oncology drugs to diagnose and treat all forms of malignancies constituting the oncology drugs market. This industry comprises manufactures of medications for treating pancreatic cancer, breast cancer, ovarian cancer, gastric cancer, kidney cancer, brain cancer, and other cancers with chemotherapy, surgery, and radiotherapy. Drugs are developed by the pharmaceutical industry to diagnose, cure, or prevent diseases. Since 2015, the worldwide oncology drugs market has grown at a compound annual growth rate (CAGR) of 9.8%, reaching over $167.9 billion in 2019. At a CAGR of 9.7%, the market is predicted to rise modestly from $201.1 billion in 2021 to $284.5 billion in 2023. The market is predicted to level out in 2025, reaching $284.5 billion and $412.9 billion by 2030.
- Strong pipeline of drugs
- Drug market: current and expected trends
- Oncology market during pandemic
- FDA rules and regulations
Rajvir Dahiya
University of California San Francisco, United States
Michael Thompson
University of Toronto, Canada
Patricia Tai
University of Saskatchewan, Canada
Can Küçük
Dokuz Eylul University, Turkey
Nadia Leney Olazo Marquez
Benemérita Universidad Autónoma de Puebla, Mexico
Ratan Kumar Sarkar
Independent Researcher, India
Mudalsha Ravina
All India Institute of Medical Sciences, IndiaSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Genetic and epigenetic alterations of SOX7 in multiple myeloma and allied neoplasms
Can Küçük, Dokuz Eylul University, Turkey
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India